GLP-1 agonists do not metabolically promote fat storage or weight gain
This is comparable to the weight loss benefits of Wegovy, the injectable version of semaglutide
The study included 3,533 people with kidney disease and Type 2 diabetes, about half of whom took a weekly injection of semaglutide, and half of whom took a weekly placebo shot
[1] Whilst Wegovy primarily targets metabolic pathways, GLP-1 receptors are also present in various brain regions, including some associated with mood regulation, though a direct link to emotional processing remains hypothetical rather than proven
Try: Reducing high-sulphur foods like eggs, red meat, garlic, onions and cruciferous vegetables
What is the best SPF lip balm to use